AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

NMRA · NASDAQ · Biotechnology

Neumora Therapeutics (NMRA)

Develops precision medicines for brain diseases using neuroscience and data science.

$1.38

At close+0.04 (+3.38%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions121 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail	≈ 37.43%	70.33M shares
Insiders7 holders · as of Aug 21, 2026	4.71%	8.86M shares
Strategic holders1 holder · as of Sep 27, 2023	18.82%	35.37M shares
Otherremainder	≈ 39.04%	73.34M shares

187.90M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Amgen IncStrategic10 percent owner	18.82%	35.37M	13Dfiled Sep 27, 2023 ↗
Siren, L.L.C.Institution	4.52%	8.50M	13Fas of Mar 31, 2026
Paul L. Berns¹Insiderdirector, officer: See Remarks	4.37%	8.23M	13Gfiled Feb 19, 2026 ↗
SoftBank Group Corp.Institution	3.24%	6.09M	13Fas of Mar 31, 2026
Perceptive Advisors LLCInstitution	2.72%	5.10M	13Fas of Mar 31, 2026
Mic Capital Management UK LLPInstitution	2.37%	4.46M	13Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution	2.07%	3.89M	13Fas of Mar 31, 2026
FMR LLCInstitution	1.86%	3.50M	13Fas of Mar 31, 2026
Wellcome Trust Ltd (The) As Trustee of the Wellcome TrustInstitution	1.76%	3.31M	13Fas of Mar 31, 2026
Millennium Management LLCInstitution	1.47%	2.75M	13Fas of Mar 31, 2026
Iconiq Capital, LLCInstitution	1.36%	2.56M	13Fas of Mar 31, 2026
Lunate Capital LtdInstitution	1.13%	2.12M	13Fas of Mar 31, 2026
BlackRock, Inc.Institution	1.09%	2.05M	13Fas of Mar 31, 2026
Two Sigma Investments, LPInstitution	1.08%	2.04M	13Fas of Mar 31, 2026
Johnson & JohnsonInstitution	0.98%	1.85M	13Fas of Mar 31, 2026
Renaissance Technologies LLCInstitution	0.74%	1.39M	13Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution	0.68%	1.28M	13Fas of Mar 31, 2026
Susquehanna International Group, LLPInstitution	0.66%	1.24M	13Fas of Mar 31, 2026
Marshall Wace, LLPInstitution	0.64%	1.20M	13Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution	0.58%	1.09M	13Fas of Mar 31, 2026
Adage Capital Partners GP, L.L.C.Institution	0.53%	1.00M	13Fas of Mar 31, 2026
Silverarc Capital Management, LLCInstitution	0.44%	818,156	13Fas of Mar 31, 2026
Tudor Investment Corp et alInstitution	0.41%	771,418	13Fas of Mar 31, 2026
Jane Street Group, LLCInstitution	0.40%	747,665	13Fas of Mar 31, 2026
Alphacore Capital LLCInstitution	0.34%	638,784	13Fas of Mar 31, 2026

Paul L. Berns's transaction reports restate only vehicles that traded; the 2025 ownership statement (8.23M) less the 23.7K net shares sold since is used instead.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

121 holders · 70.33M shares · 24 new positions · 59 increased · 31 reduced · 13 closed

Holder	Shares	% outstanding	Chg q/q	Filed
Siren, L.L.C.	8.50M	4.52%	+2.21M	May 14, 2026
SoftBank Group Corp.	6.09M	3.24%	−339.4K	May 15, 2026
Perceptive Advisors LLC	5.10M	2.72%	+5.10Mnew	May 29, 2026
Mic Capital Management UK LLP	4.46M	2.37%	0	May 13, 2026
Vanguard Capital Management LLC	3.89M	2.07%	+3.89Mnew	May 15, 2026
FMR LLC	3.50M	1.86%	+389	May 15, 2026
Wellcome Trust Ltd (The) As Trustee of the Wellcome Trust	3.31M	1.76%	0	Apr 22, 2026
Millennium Management LLC	2.75M	1.47%	−861.7K	May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Kristina Burowincl. ARCH Venture Fund XII, L.P., ARCH Venture Partners VII, L.P. +15 more	18.70%	33.97M	13D	Apr 1, 2026 ↗
Paul L Berns	5.10%	8.23M	13G	Feb 13, 2025 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Aug 21, 2026	Daljit Singh Auroraofficer: See Remarks	Sale · 2 lots	41,608	$1.60	48,750
Aug 20, 2026	Daljit Singh Auroraofficer: See Remarks	Sale · 2 lots	134,452	$1.51	48,750
Aug 19, 2026	Daljit Singh Auroraofficer: See Remarks	Sale · 2 lots	61,918	$1.65	48,750
Aug 18, 2026	Daljit Singh Auroraofficer: See Remarks	Sale · 2 lots	69,149	$1.59	48,750
Aug 17, 2026	Daljit Singh Auroraofficer: See Remarks	Sale · 3 lots	146,706	$1.50	48,750
Feb 17, 2026	Michael Lee Milliganofficer: See Remarks	Sale	1,436	$3.57	21,034
Feb 17, 2026	Paul L. Bernsdirector, officer: See Remarks	Sale	9,819	$3.51	7,395,185
Feb 17, 2026	Joshua Pintoofficer: President	Sale	5,967	$3.54	57,783
Feb 17, 2026	Daljit Singh Auroraofficer: See Remarks	Sale	6,165	$3.56	82,770
Nov 11, 2025	Daljit Singh Auroraofficer: See Remarks	Sale	114,703	$2.68	0

CongressHouse and Senate disclosures

Not reported.